United States · FDA National Drug Code directory
XELJANZ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-1001_40c4e5e1-3891-4949-bd0e-db319cc1e813
- Product NDC
- 0069-1001
- Form
- TABLET, FILM COATED
- Composition / generic term
- tofacitinib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20121109
- Source listing expiry
- 20271231
Source-listed ingredients
- TOFACITINIB CITRATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (0069-1001-01) · 0069-1001-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →